Tomorrow the German Carl Zeiss Meditec will report its past quarter results. For this year Carl Zeiss Meditec's revenue will be around 1,42 billion euros. This is according to the average of the analysts' estimates. This is rather significant more than 2018's revenue of 1,28 billion euros.
The analysts expect for 2019 a net profit of 164 million euros. According to most of the analysts the company will have a profit per share for this book year of 1,84 euros. With this the price/earnings-ratio is an extreme 51,03.
Per share the analysts expect a dividend of 0,63 cents per share. Thus the dividend yield equals 0,67 percent. The average dividend yield of the pharmaceutical companies is a limited -3 percent.
Based on the current number of shares Carl Zeiss Meditec's market capitalization equals 8,4 billion euros. The Carl Zeiss Meditec stock was the past 12 months quite volatile. Since last August the stock is even 38 percent higher. This year the stock price moved between 60 and 101 euro.At 13.07 the stock trades 0,53 percent higher at 93,9 euros.
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.